Lv3
310 积分 2025-05-10 加入
Integrating novel therapeutic strategies in myeloproliferative neoplasms: Driving disease-directed progress
24天前
已完结
Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study
4个月前
已完结
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial
4个月前
已完结
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
5个月前
已完结
Prolonged use of eltrombopag in patients with severe aplastic anemia in the real world
5个月前
已完结
A real-world experience of eltrombopag plus rabbit antithymocyte immunoglobulin–based IST in Chinese patients with severe aplastic anemia
5个月前
已完结
Second malignancies in hydroxyurea and interferon‐treated Philadelphia‐negative myeloproliferative neoplasms
7个月前
已完结
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
7个月前
已完结
Review for "High-Grade B-cell lymphomas with MYC and BCL2 translocations lack tumor-associated macrophages and PD-L1 expression: A possible noninflamed subgroup"
7个月前
已关闭
Clinicopathologic Analysis of Primary Adrenal Diffuse Large B-Cell Lymphoma
7个月前
已完结
皖公网安备34019202002308
